Aberrant c-Myc expression has been observed in ~ 70% of human cancers by driving autonomous cell cycle progression, recruitment of inflammatory cells, blocking differentiation, extensive stromal remodeling, invasion, and angiogenesis. This evidence concerns the gene MYC and cancer.